Basel Medical Group Ltd Ordinary Shares Price & Performance (BMGL)

Basel Medical Group Ltd has finalized the sale of an additional 330,750 shares under its IPO overallotment option, raising $1.32 million. This brings the total gross proceeds from its offering to $10.14 million. The funds will support business expansion, mergers, and daily operations, as the company strengthens its market position.12

Orchid Island Capital has announced a monthly dividend of $0.12 per share for March 2025. The company also released updated metrics for its RMBS portfolio as of February 28. These updates reflect its ongoing strategy as a REIT, requiring annual distribution of 90% of taxable income to shareholders.3

Basel Medical Group Ltd priced its IPO at $4.00 per share, raising $8.82 million through the sale of over 2.2 million shares. The funds will be allocated towards mergers, clinic expansions, and operational upgrades. The shares began trading on Nasdaq under the ticker "BMGL" on February 25, 2025.45